Federal Register of Legislation - Australian Government

Primary content

PB 58 of 2010 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) to provide for conditions for payments in respect of supply of pharmaceutical benefits by approved pharmacists and medical practitioners.
Administered by: Health
Registered 21 Jun 2010
Tabling HistoryDate
Tabled HR22-Jun-2010
Tabled Senate22-Jun-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 58 of 2010

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, FELICITY McNEILL, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated 3rd June 2010

 

 

 

 

 

FELICITY McNEILL

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing


Amendment determination — conditions

1              Commencement                                                        

                This instrument commences on 1 July 2010.

2              Amendment of PB 119 of 2008

                Schedule 1 amends PB 119 of 2008.



Schedule 1            Amendments

 

[1]      Schedule 4, item dealing with Glucose Indicator—Blood

(a) insert as first entry in the column headed “Form (strength, type, size, etc.)”:

 

 

Test strips, 100 (Accu-Chek Active)

(b) omit from the column headed “Form (strength, type, size, etc.)”:

 

 

Test strips, 100 (SofTact)

[2]      Schedule 4, omit item dealing with Mesalazine

[3]      Schedule 4, omit item dealing with Metformin

[4]      Schedule 4, item dealing with Oestradiol

omit from the column headed “Form (strength, type, size, etc.)”:

 

 

Transdermal patches 4 mg, 8

[5]      Schedule 4, item dealing with Oestradiol and Oestradiol with Norethisterone

omit from the column headed “Form (strength, type, size, etc.)”:

 

 

Pack containing 4 transdermal patches oestradiol 4 mg and 4 transdermal patches oestradiol 10 mg with norethisterone acetate 30 mg